IDENTIFICATION OF SILDENAFIL CITRATE AS AN ADULTERANT IN HERBAL PRODUCTS USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH PHOTODIODE ARRAY DETECTOR

  • Mohammad Al-amin Department of Pharmacy, East West University, Plot no-A/2, Jahurul Islam City, Aftabnagar, Dhaka-1212, Bangladesh, 2Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia
  • Gazi Nurun Nahar Sultana Centre for Advanced Research in Sciences (CARS), University of Dhaka, Dhaka 1000, Bangladesh
  • Chowdhury Faiz Hossain Department of Pharmacy, East West University, Plot no-A/2, Jahurul Islam City, Aftabnagar, Dhaka-1212, Bangladesh,

Abstract

Objective: Investigation of sildenafil citrate as an adulterant in the traditional liquid herbal products of the local market in Bangladesh.

Methods: A reversed-phase high-performance liquid chromatographic (HPLC) method with photodiode array (PDA) detector system has been developed and validated for investigating the presence of synthetic phosphodiesterase 5 (PDE-5) enzyme inhibitor as an adulterant in the traditional herbal products. Nine of the liquid preparations (syrup), Balarista (A), Jinsant (B), Jernide (C), Bolarist (D), Sree Gopal Oil (E), Menostroge (F), Enerton (G), Ginseng (H) and Ginsin Plus (I), of six companies form local market of Bangladesh were investigated.

Results: All the products (A–I) were found to contain sildenafil citrate as an adulterant. HPLC peak of the adulterant was confirmed by comparing retention time, UV spectra generated by PDA detector and peak spiking with the authentic sample of sildenafil citrate. The quantity of sildenafil citrate in A, B, C, D, E, F, G, H and I syrups were found to be 17, 22, 26, 25, 10, 24, 29, 22 and 17 mg/100 ml, respectively.

Conclusion: The study indicated that all tested liquid herbal products contain sildenafil citrate as an adulterant. As PDE-5 inhibitors have severe side effects, possess drug-drug interaction and highly recommended to prescribe by registered physicians, the regulatory agency of Bangladesh should take necessary action to minimize the risk of patients.

Keywords: PDE-5 inhibitor, Herbal, Adulterant, Male erectile dysfunction (ED), HPLC

Downloads

Download data is not yet available.

Author Biographies

Mohammad Al-amin, Department of Pharmacy, East West University, Plot no-A/2, Jahurul Islam City, Aftabnagar, Dhaka-1212, Bangladesh, 2Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia

Graduate Student

Department of Pharmaceutical Chemistry

School of Pharmaceutical Sciences

Universiti Sains Malaysia

11800 USM, Penang,

Malaysia

Gazi Nurun Nahar Sultana, Centre for Advanced Research in Sciences (CARS), University of Dhaka, Dhaka 1000, Bangladesh

Chief Scientist

Centre for Advanced Research in Sciences (CARS)

University of Dhaka

Dhaka-1000

Bangladesh.

Chowdhury Faiz Hossain, Department of Pharmacy, East West University, Plot no-A/2, Jahurul Islam City, Aftabnagar, Dhaka-1212, Bangladesh,

Professor and Chaiperson

Department of Pharmacy

East West University

A/2 Jahurul Islam Avenue

Aftabnagar, Dhaka-1212

Bangladesh.

References

1. Jeon YH, Heo YS, Kim CM, Hyun YL, Lee TG, Ro S, et al. Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell Mol Life Sci 2005;62:1198-220.
2. Pissarnitski D. Phosphodiesterase 5 (PDE-5) inhibitors for the treatment of male erectile disorder: Attaining selectivity versus PDE6. Med Res Rev 2006;26:369-95.
3. Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G. Pharmacology. 7nded. Ireland: Elsevier; 2012.
4. Blok-Tip L, Zomer B, Bakker F, Hartog KD, Hamzink M, Ten Hove J, et al. Structure elucidation of sildenafil analogues in herbal products. Food Addit Contam 2004;21:737-48.
5. Gratz SR, Flurer CL, Wolnik KA. Analysis of undeclared synthetic phosphodiesterase-5 inhibitors in dietary supplements and herbal matrices by LC–ESI–MS and LC–UV. J Pharm Biomed Anal 2004;36:525-33.
6. Patel DN, Low WL, Tan LL, Tan MMB, Zhang Q, Low MY, et al. Adverse events associated with the use of complementary medicine and health supplements: An analysis of reports in the Singapore Pharmacovigilance database from 1998 to 2009. Clin Toxicol 2012;50:481-9.
7. Savaliya AA, Shah RP, Prasad B, Singh S. Screening of Indian aphrodisiac ayurvedic/herbal healthcare products for adulteration with sildenafil, tadalafil and/or vardenafil using LC/PDA and extracted ion LC–MS/TOF. J Pharm Biomed Anal 2010;52:406-9.
8. Podder AK, Chakrobarty JK, Faroque ABM. Qualitative and quantitative analysis of sildenafil in traditional medicines and dietary supplements. Asian J Pharm Clin Res 2014;7 Suppl 1:25-30.
9. Hassali MA, Shafie AA, Khalid Y, Hari R. Assessment of knowledge and perception of erectile dysfunction among diabetic and non-diabetic patients at a university health center in Malaysia. Asian J Pharm Clin Res 2009;2:60-5.
10. Ravisankar P, Rao GD. Development and validation of RP-HPLC method for determination of levamisole in bulk and dosage form. Asian J Pharm Clin Res 2013;6 Suppl 3:169-73.
11. Lam YH, Poon WT, Lai CK, Chan AYW, Mak TWL. Identification of a novel vardenafil analogue in the herbal product. J Pharm Biomed Anal 2008;46:804-7.
12. Tseng MC, Lin JH. Determination of sildenafil citrate adulterated in a dietary supplement capsule by LC/MS/MS. J Food Drug Anal 2002;10:112-9.
13. Goker H, Coskun M, Ayhan-Kilcigil G. Chromatographic separation and identification of sildenafil and yohimbine analogues illegally added in herbal supplements. Chromatographic and Its Applications. Dr. Sasikumar Dhanarasu (Ed.) InTech; 2012.
Statistics
292 Views | 498 Downloads
Citatons
How to Cite
Al-amin, M., G. N. N. Sultana, and C. F. Hossain. “IDENTIFICATION OF SILDENAFIL CITRATE AS AN ADULTERANT IN HERBAL PRODUCTS USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH PHOTODIODE ARRAY DETECTOR”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 10, no. 9, Sept. 2018, pp. 15-20, doi:10.22159/ijpps.2018v10i9.26425.
Section
Original Article(s)